Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Fintech Innovation ETF (ARKF) vs Novavax Inc (NVAX) Price & Performance

ARK Fintech Innovation ETFTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

ARK Fintech Innovation ETF vs Novavax Inc — how do they compare? ARK Fintech Innovation ETF trades at $43, while Novavax Inc trades at $7.95 (market cap $1.30B). Which is the better fit depends on your goals.

ARKFNVAX
Sector
Sector/ThematicHealth
52-Week High
$58.82$11.19
52-Week Low
$36.14$6.22
Market Cap
$1.30B
Enterprise Value
$879.40M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Fintech Innovation ETF

ARKF trades at $42.54, up 1.48% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF has underperformed the S&P 500, down 23% since July 2025, and faces elevated volatility. Recent news highlights its fintech and crypto exposure amid market consolidation, with a Hold rating due to fair valuation concerns.

Outlook remains cautious; high P/E of 33x and PEG of 2.0x suggest overvaluation risks, while sector consolidation offers potential recovery if market sentiment improves. Key risks include sustained underperformance and portfolio volatility, requiring careful monitoring of fintech sector trends.

Novavax Inc

Novavax (NVAX) trades at $7.95, up 2.71% with a bullish technical signal despite negative profitability metrics. The company shows mixed fundamentals with strong revenue growth to $1.12B in 2025 but negative net income margins. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook while cutting expenses. Analyst sentiment remains positive with 74% buy ratings.

Investment outlook balances strong partnerships and pipeline potential against persistent cash burn and negative equity. The Sanofi collaboration and Matrix-M adjuvant platform offer growth catalysts, but operational losses and high debt levels present significant risks. Stock appears undervalued on some metrics but requires careful monitoring of cash flow sustainability.

Returns comparison

Trailing returns across standard periods

About ARK Fintech Innovation ETF

ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.

Read more on ARKF

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX